Silvan Tuerkcan

Stock Analyst at JMP Securities

(3.29)
# 1,149
Out of 4,452 analysts
108
Total ratings
44.72%
Success rate
2.36%
Average return

17 Stocks

Cellectis
May 31, 2024
Reiterates: Market Outperform
Price Target: $6
Current: $2.25
Upside: +166.67%
Vor Biopharma
May 13, 2024
Reiterates: Market Outperform
Price Target: $12
Current: $1.15
Upside: +943.48%
MacroGenics
May 10, 2024
Maintains: Market Outperform
Price Target: $22$16
Current: $4.47
Upside: +257.94%
CRISPR Therapeutics AG
May 9, 2024
Reiterates: Market Outperform
Price Target: $86
Current: $63.56
Upside: +35.31%
Relay Therapeutics
May 6, 2024
Reiterates: Market Outperform
Price Target: $24
Current: $7.31
Upside: +228.32%
Terns Pharmaceuticals
Apr 30, 2024
Reiterates: Market Outperform
Price Target: $15
Current: $8.20
Upside: +82.93%
Acrivon Therapeutics
Apr 25, 2024
Maintains: Market Outperform
Price Target: $14$17
Current: $7.25
Upside: +134.48%
Benitec Biopharma
Apr 22, 2024
Maintains: Market Outperform
Price Target: $10$16
Current: $7.31
Upside: +118.88%
Notable Labs
Apr 15, 2024
Reiterates: Market Outperform
Price Target: $9
Current: $0.68
Upside: +1,223.53%
Exelixis
Apr 10, 2024
Reiterates: Market Outperform
Price Target: $27
Current: $21.74
Upside: +24.20%
Taysha Gene Therapies
Mar 20, 2024
Reiterates: Market Outperform
Price Target: $5
Current: $3.97
Upside: +25.94%
Elevation Oncology
Mar 7, 2024
Reiterates: Market Outperform
Price Target: $7
Current: $3.23
Upside: +116.72%
monday.com
Mar 5, 2024
Maintains: Buy
Price Target: $240$280
Current: $226.58
Upside: +23.58%
Generation Bio Co.
Oct 23, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $2.74
Upside: -
Two Harbors Investment
Jan 26, 2023
Maintains: Market Outperform
Price Target: $18$18
Current: $12.98
Upside: +38.67%
Intellia Therapeutics
Jan 19, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $25.15
Upside: -
ContextLogic
May 10, 2022
Maintains: Market Outperform
Price Target: $2$3
Current: $5.43
Upside: -44.75%